Article
Investigation of transcription factor AP-2 beta genotype in women with premenstrual dysphoric disorder.
Neuroscience letters - 22 Mar 2005
Damberg Mattias, Westberg Lars, Berggård Cecilia, Landen Mikael, Sundblad Charlotta, Eriksson Olle, Naessén Tord, Ekman Agneta, Eriksson Elias
Abstract excerpt
It has repeatedly been shown that the serotonergic system is involved in the symptomatology of premenstrual dysphoric disorder (PMDD). Women with PMDD are reported to differ from symptom-free controls with regard to serotonin-related biological markers. Evidence from family and twin studies suggests a genetic contribution to the aetiology of PMDD. The expression of human transcription factor AP-2beta in neural...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
